Clin2
NCT07337174Likely a fitNot yet recruiting

Comparing two versions of an injected study drug in healthy adults

Obesity

Part of Hormones & metabolism clinical trials.

This trial tests two similar versions of an injected study drug to see if they are equally safe and how the body processes them. It is for healthy volunteers only, not for treating a disease.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
19 years to 65 years
Study type
Interventional

Who can take part

  • You must be between 19 and 65 years old.
  • You must be in good general health with no significant current or past medical conditions.
  • If you are female, you cannot be pregnant or breastfeeding.
  • You must be willing to give written consent to participate and follow the study rules.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07768813Recruiting· Phase 1
Comparing two versions of an injected drug in healthy and overweight people

This trial compares two different versions of an injected study drug (survodutide) to see how they are absorbed by the body. It is open to healthy people and people with overweight or obesity, and it may help researchers find a better way to deliver this treatment.

Mannheim
NCT07716241Not yet recruiting· Phase 1
Study of an investigational injection for weight management in healthy or overweight adults

This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.

Hefei
NCT06934408Recruiting· Phase 1
Safety study of HRS-5817 injection in healthy adults

This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.

Hefei, Anhui
NCT07702890Recruiting· Phase 1/Phase 2
Testing a new drug for obesity and type 2 diabetes

This trial tests an investigational drug called GUB-UCN2 in people who are healthy, overweight, or have type 2 diabetes. The goal is to see if the drug is safe and how the body processes it.

Neuss
NCT07219589Recruiting· Phase 1
Study of HM17321 in healthy and obese participants

This trial tests a new medicine, HM17321, to see how the body processes it. It is for healthy adults and adults with obesity who want to help find new treatment options.

Cincinnati, Ohio
NCT07297693Not yet recruiting· Phase 1
Comparing two versions of a medication in healthy adults

This trial compares two different forms of a medication to see how they are absorbed and processed by the body and to check that they are safe. It is an early-stage study in healthy volunteers.

Seoul, Gwanak-gu

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.